Macimorelin acetate

(Macrilen®)

Macrilen®

Drug updated on 1/4/2024

Dosage FormSuspension (oral: 60 mg)
Drug ClassGrowth hormone secretagogue receptor agonists
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for the diagnosis of adult growth hormone deficiency.

Product Monograph / Prescribing Information

Document TitleYearSource
Macrilen (macimorelin acetate) Prescribing Information.2021Novo Nordisk Inc., Plainsboro, NJ

Randomized Controlled Trials

Document TitleSex DistributionYearSource
Macimorelin as a diagnostic test for adult GH deficiency.
157Subjects
F: 41%
M: 59%
2018The Journal of Clinical Endocrinology & Metabolism

Sex Distribution:

F:41%
M:59%
157Subjects

Year:

2018

Source:The Journal of Clinical Endocrinology & Metabolism

Clinical Practice Guidelines